People | February 23, 2022
Dr Fabrice Egros gets an additional role at Lupin
He will continue to lead business in LATAM and Asia regions in this new role
He will continue to lead business in LATAM and Asia regions in this new role
The investment in Indian clinical technology expertise in Hyderabad comes amid the clinical trials sector's move towards decentralised trials
The transaction as well as the open offer is expected to be completed by June this year.
The sale is expected to close in the first quarter of 2022
Dr. Reddy’s, will focus its resources and capabilities on its key therapy spaces of gastroenterology, pain management, cold and flu, allergy, oncology, neurology, paediatrics and women’s health as the Russia and CIS region continues to be a strong performer for the company
The companies plan to use the proceeds to retire debt and expand operations
Launching Dexamethasone, Azacitidine, Carboprost, and Atropine for the Institutional Market
The newly enhanced drug development platform will help empower innovators with the fastest development timelines
Waksal holds a successful track record of founding, scaling and advising growth-oriented companies.
Agilent will integrate the technology into its lab informatics platforms, enabling customers to automate GC/MS data analysis
Subscribe To Our Newsletter & Stay Updated
